Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1386
| Despition | High-Mobility Group Nucleosome Binding Domain 1 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1640 | Human Human GDF11 Protein (AC1640) | 100 µg | inquiry |
| ACPP-1513 | Human FGFR2 Protein (AC1513) | 2 µg | inquiry |
| ACPP-1117 | Human BDNF Protein (AC1117) | 2 µg | inquiry |
| ACPP-1748 | Human PAFAH1B3 Protein (AC1748) | 5 µg | inquiry |
| ACPP-1261 | TSH beta Blocking Peptide (AC1261) | 250 µg | inquiry |
| ACPP-1350 | Presenilin 2 Blocking Peptide (AC1350) | 250 µg | inquiry |
| ACPP-1281 | ULK1 Blocking Peptide (AC1281) | 250 µg | inquiry |
| ACPP-1662 | Human POFUT1 Protein (AC1662) | 5 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.